跳至主要内容
临床试验/ACTRN12623000986673
ACTRN12623000986673尚未招募Unknown

Optimal Ruptured Aneurysm CLosure via Endovascular-FIRST TREAtmeant Timing (ORACLE-FIRST TREAT): a patient-specific machine learning clinical prediction model for pre-treatment re-bleeding prevention following saccular aneurysmal subarachnoid haemorrhage

Department of Neurosurgery0 个研究点目标入组 1,009 人开始时间: 2023年9月11日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
1,009

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The Sir Charles Gairdner Hospital (SCGH) saccular aneurysmal subarachnoid haemorrhage database contains prospectively collected data for patients 18 years or over admitted to SCGH in Nedlands, Western Australia (WA) between 1st January 2009 and 31st December 2022 inclusive with aneurysmal SAH confirmed using either non-contrast computerised tomography (CT) brain scanning and/or cerebrospinal fluid spectroscopic analysis due to the rupture of a singular culprit saccular cerebral aneurysm as identified on CT-angiography, magnetic resonance angiography and/or digital subtraction catheter angiography.

排除标准

  • Patients were excluded from the study population if they experienced cryptogenic subarachnoid haemorrhage (SAH), peri-mesencephalic SAH, SAH due to arterial dissection, fusiform, mycotic or blister type aneurysm, recurrent SAH from a previously treated saccular aneurysm or SAH due to a ruptured arteriovenous malformation.

研究者

相似试验